The global market for Artificial Intelligence in precision medicine, valued at USD 1.68 billion in 2022, is poised for dramatic expansion. It is expected to reach USD 17.15 billion by 2031, growing at a robust CAGR of 26.4% during the forecast period 2024 to 2031.
Market Overview
Artificial Intelligence (AI) is reshaping precision medicine by enabling data-rich, patient-specific approaches to disease prevention, diagnosis, and treatment. AI technologies such as machine learning, natural language processing, and predictive analytics are empowering healthcare professionals to deliver more personalized therapies with higher accuracy and improved outcomes.
Request Latest Updated Sample Report Now! https://www.statsandresearch.com/request-sample/40461-global-artificial-intelligence-in-precision-medicine-market
The integration of AI tools into genomics, drug discovery, and clinical diagnostics has accelerated the shift toward precision-based care models. This shift is particularly critical as the global healthcare ecosystem continues to prioritize early detection, treatment accuracy, and patient-centric services. The rapidly growing access to healthcare datasets and advances in computing power are driving this evolution.
As pharmaceutical companies, hospitals, and research institutions increasingly embrace AI-powered platforms, the Artificial Intelligence in Precision Medicine Market is experiencing unprecedented momentum.
Growth Opportunities
The market's exceptional growth prospects are supported by several driving factors:
- Growing demand for tailored treatment protocols in oncology, cardiology, and neurology.
- Expansion of genomics databases and electronic health records (EHRs).
- Rising investments by pharmaceutical and biotech companies in AI-assisted drug development.
- Emergence of AI-integrated wearable devices and health monitoring tools.
- Collaborations between AI startups and healthcare providers to streamline clinical decision-making.
The convergence of healthcare data with AI-driven analytics creates fertile ground for innovation, making this sector one of the most promising fields in digital health.
Key Takeaways from Report
- The market stood at USD 1.68 billion in 2022 and is projected to grow to USD 17.15 billion by 2031.
- The growth rate during the forecast period 2024–2031 is estimated at an impressive CAGR of 26.4%.
- AI-driven diagnostics, genomics research, and clinical decision support systems are among the key growth drivers.
- Pharmaceutical firms are increasingly leveraging AI to reduce drug development timelines and costs.
- AI algorithms are transforming the way chronic conditions and rare diseases are managed and treated.
Regional Analysis
North America dominates the Artificial Intelligence in Precision Medicine Market due to its advanced healthcare infrastructure, strong research capabilities, and widespread adoption of AI technologies. The presence of leading biotech firms, academic research centers, and regulatory support provides a robust foundation for market expansion.
The United States, in particular, is at the forefront of AI-driven healthcare innovation. Government initiatives such as the Precision Medicine Initiative and increasing funding in AI research have significantly accelerated technology adoption in clinical practices.
Europe is emerging as a key region due to the growing focus on personalized healthcare and strategic partnerships between AI startups and medical institutions. Countries such as Germany, the UK, and France are witnessing rising integration of AI tools into diagnostic imaging and genomics analysis.
Asia Pacific is anticipated to witness the fastest growth over the forecast period. This is attributed to rising healthcare investments, increased digital health adoption, and efforts by countries like China and India to build AI-based healthcare ecosystems. Supportive government policies and expanding patient datasets are further contributing to regional market growth.
Request Upto 40% Discount on This Report! https://www.statsandresearch.com/check-discount/40461-global-artificial-intelligence-in-precision-medicine-market
Major Players:
- BioXcel Therapeutics, Inc.
- Sanofi S.A.
- NVIDIA Corp.
- Alphabet Inc. (Google Inc.)
- IBM
- Microsoft
- Intel Corp.
- AstraZeneca plc
- GE HealthCare
- Enlitic, Inc.
Market Segmentation
The Artificial Intelligence in Precision Medicine Market can be segmented based on the following key categories:
Application:
- Oncology
- Cardiology
- Neurology
- Respiratory
- Immunology
- Others
Technology:
- Machine Learning
- Deep Learning
- Natural Language Processing
- Computer Vision
- Others
End-user:
- Healthcare Providers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
Our Services:
On-Demand Reports: https://www.statsandresearch.com/on-demand-reports
Subscription Plans: https://www.statsandresearch.com/subscription-plans
Consulting Services: https://www.statsandresearch.com/consulting-services
ESG Solutions: https://www.statsandresearch.com/esg-solutions
Contact Us:
Stats and Research
Email: sales@statsandresearch.com
Phone: +91 8530698844
Website: https://www.statsandresearch.com